Sickle Cell Disease
6.7
3
66
The FDA approved two new therapies for sickle-cell disease, including the wor...
The United States on Friday approved a breakthrough medicine that uses revol...
The FDA's approval of Casgevy, which uses the Nobel Prize-winning gene-editin...
The U.S. Food and Drug Administration (FDA) on Friday approved a pair of gene...
The Food and Drug Administration announced last week that it's investigating ...
Makers of both the therapies have pitched them as one-time treatments, but data on how long their effect lasts is lim...
The Food and Drug Administration on Friday approved two gene therapies to treat patients with sickle cell disease. Th...
In the world’s first CRISPR-based treatment, genetic tweaks to red blood cell...
The painful, inherited blood disorder afflicts mostly Black people in the U.S.
Two new therapies—one which uses the gene-editing technology—treat sickle cell anemia.
The Food and Drug Administration on Friday approved the first drug that uses this technology to treat an illness, sic...
The treatment promises potential relief – and possibly a cure – for the condition that affects some 100,000 Americans...
Therapy for sickle-cell disease is the first Crispr-based treatment approved ...
The Food and Drug Administration approved a new gene editing therapy for sick...
The therapies offer hope for a long-overlooked genetic illness that can cause...
Sickle cell disease is a blood disorder that affects about 100,000 people in the United States.
The U.S. FDA on Friday approved two gene therapies for sickle cell disease from Vertex Pharmaceuticals and CRISPR The...
Casgevy was developed by Boston-based Vertex Pharmaceuticals and CRISPR Therapeutics, which is headquartered in Zug, ...
People with the genetic disease have new opportunities to eliminate their sym...
The Food and Drug Administration has approved the world's first medicine empl...
1